{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:51:32Z","timestamp":1783691492731,"version":"3.55.0"},"reference-count":62,"publisher":"Frontiers Media SA","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1432-2277.2008.00796.x","type":"journal-article","created":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T14:10:17Z","timestamp":1228745417000},"page":"49-60","source":"Crossref","is-referenced-by-count":80,"title":["Calcineurin inhibitor minimization protocols in liver transplantation"],"prefix":"10.3389","volume":"22","author":[{"given":"Stefan A.","family":"Farkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas A.","family":"Schnitzbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Obed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Banas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","reference":[{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/tr.2000.5377","article-title":"Immunosuppressant-induced metabolic toxicities","volume":"14","author":"Danovitch","year":"2000","journal-title":"Transplant Rev"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-2277.2004.00043.x","article-title":"Post-transplant diabetes mellitus: a case-control analysis of the risk factors","volume":"18","author":"Romagnoli","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB3","first-page":"34","article-title":"Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations","volume":"17","author":"Andoh","year":"1997","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB5","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1212\/WNL.45.11.1962","article-title":"Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression","volume":"45","author":"Wijdicks","year":"1995","journal-title":"Neurology"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","article-title":"Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies","volume":"7","author":"Olyaei","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB8","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/lt.20618","article-title":"Kidney dysfunction in the recipients of liver transplants","volume":"11","author":"Wilkinson","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1432-2277.2006.00280.x","article-title":"Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation","volume":"19","author":"Alexander","year":"2006","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-2277.2004.tb00444.x","article-title":"Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors","volume":"17","author":"Nashan","year":"2004","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1432-2277.2004.00032.x","article-title":"Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience","volume":"18","author":"Weber","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB12","first-page":"152","article-title":"Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria","volume":"21","author":"Diekmann","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB13","doi-asserted-by":"crossref","first-page":"220S","DOI":"10.1016\/j.transproceed.2004.01.028","article-title":"Cyclosporine nephrotoxicity","volume":"36","author":"Fellstrom","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.healun.2005.05.018","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report - 2005","volume":"24","author":"Taylor","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: a retrospective analysis","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1399-0012.2003.00132.x","article-title":"Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease","volume":"18","author":"Paramesh","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1523-1755.1998.00004.x","article-title":"Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation","volume":"54","author":"Fraley","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB19","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/jlts.2001.21304","article-title":"Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients","volume":"7","author":"Singh","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB21","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/S0041-1345(99)00666-1","article-title":"Risk factors for postoperative acute renal failure at a new orthotopic liver transplantation program","volume":"31","author":"vares-da-Silva","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0041-1345(01)02747-6","article-title":"Evaluation of acute renal failure in the liver transplantation perioperative period: incidence and impact","volume":"34","author":"Gainza","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB23","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/lt.20445","article-title":"Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation","volume":"11","author":"Campbell","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.ki.5000216","article-title":"Risk factors of acute renal failure after liver transplantation","volume":"69","author":"Cabezuelo","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1399-0012.2008.00806.x","article-title":"Chronic renal dysfunction following liver transplantation","volume":"22","author":"Schmitz","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/gut.52.1.134","article-title":"MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study","volume":"52","author":"Botta","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.mcg.0000180640.98671.7f","article-title":"Longitudinal modifications of the MELD score have prognostic meaning in patients with liver cirrhosis","volume":"39","author":"Giannini","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1034\/j.1600-6143.2003.00092.x","article-title":"Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C","volume":"3","author":"Onaca","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/lt.20686","article-title":"Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation","volume":"12","author":"Machicao","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.20490","article-title":"Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial","volume":"11","author":"Yoshida","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/lt.21185","article-title":"Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation","volume":"13","author":"Soliman","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/lt.21309","article-title":"Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors","volume":"14","author":"Bajjoka","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB36","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/lt.20903","article-title":"Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation","volume":"12","author":"Pageaux","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lt.20144","article-title":"Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage","volume":"10","author":"Liu","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.TP.0000116562.15920.43","article-title":"Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation","volume":"77","author":"Tzakis","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/lt.500050513","article-title":"Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil","volume":"5","author":"Herrero","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hep.510240518","article-title":"Cyclosporin A: drug discontinuation for the management of long-term toxicity after liver transplantation","volume":"24","author":"Chan","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(00)04055-1","article-title":"Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study","volume":"357","author":"Schlitt","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/lt.20926","article-title":"Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension","volume":"13","author":"Orlando","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/lt.21452","article-title":"Sirolimus conversion for renal preservation in liver transplantation: not so fast","volume":"14","author":"Jensen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB44","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/lt.21314","article-title":"A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function","volume":"13","author":"Watson","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.tp.0000261630.63550.41","article-title":"Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial","volume":"83","author":"Shenoy","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jlts.2003.50183","article-title":"Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus","volume":"9","author":"Fairbanks","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jlts.2003.50026","article-title":"Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients","volume":"9","author":"Nair","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.21429","article-title":"Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens","volume":"14","author":"DuBay","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/jlts.2000.19023","article-title":"Experience with the use of sirolimus in liver transplantation - use in patients for whom calcineurin inhibitors are contraindicated","volume":"6","author":"Chang","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB50","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/00007890-200005150-00025","article-title":"Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil","volume":"69","author":"Barkmann","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncpneph0225","article-title":"Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts","volume":"2","author":"Liptak","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB52","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB53","first-page":"39","article-title":"Renal transplant morphology after long-term therapy with cyclosporine","volume":"27","author":"Mihatsch","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB54","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1016\/j.transproceed.2004.01.027","article-title":"Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?","volume":"36","author":"Morozumi","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB55","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1600-6143.2007.02142.x","article-title":"Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients","volume":"8","author":"Aliabadi","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB56","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJM200511103531922","article-title":"Post-transplantation proteinuria and sirolimus","volume":"353","author":"Izzedine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-2277.2008.00642.x","article-title":"Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death","volume":"21","author":"Schadde","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-3062.2006.00149.x","article-title":"Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab","volume":"9","author":"Silveira","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB59","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-0012.2008.00816.x","article-title":"Herpes zoster infection after liver transplantation in patients receiving induction therapy with alemtuzumab","volume":"22","author":"Alcaide","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1432-2277.2006.00343.x","article-title":"The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation","volume":"19","author":"Magliocca","year":"2006","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1111\/j.1432-2277.2008.00796.x-BIB62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/FTD.0b013e31816b9063","article-title":"Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges","volume":"30","author":"Christians","year":"2008","journal-title":"Ther Drug Monit"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2008.00796.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2008.00796.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:38:48Z","timestamp":1641062328000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2008.00796.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00796.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"value":"0934-0874","type":"print"},{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}